Immune Checkpoint Inhibitors in Hodgkin Lymphoma

Sort by:
Relevance Thumbs Up Comments Views Newest Oldest
10:07

UChicago Annual Updates from ASH 2019

ASH 2019 Updates on Hodgkin Lymphoma: Frontline Brentuximab + Nivo in Pts > 60 & PET-adapted Nivo + ICE in First Relapse

FEATURING Justin Kline
  • 314 views
  • March 20, 2020
08:39

Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)

Next Questions in Hodgkin Lymphoma: Brentuximab Vedotin/PD-1+AVD as Frontline in Advanced Disease, as Consolidation Therapy, and Other New Drugs

FEATURING Stephen M. Ansell
  • 416 views
  • October 18, 2019
  • 3
08:48

Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)

Checkpoint Inhibition Before Haploidentical Stem Cell Transplantation in R/R Hodgkin Lymphoma is Associated with Higher PFS Without Increased Toxicities

FEATURING Chiara de Philippis
  • 26 views
  • October 18, 2019
22:48

ESO Lymphoma Course

Biology of Hodgkin Lymphoma: Relationship Between Hodgkin and Reed-Sternberg Cells & Gene Expression Profiling Analysis of CD30+ B vs. HRS Cells

FEATURING Ralf Küppers
  • 22 views
  • September 12, 2019
28:05

ESO Lymphoma Course

Biology of Hodgkin Lymphoma: IgV Gene Rearrangements, Factors Contributing to Lost B Cell Identity of HRS Cells & Genetic Lesions in HRS Cells

FEATURING Ralf Küppers
  • 22 views
  • September 12, 2019
39:10

ESO Lymphoma Course

Hodgkin Lymphoma - Kairos vs. Chronos Principle & New Active Agents (Antibody-Drug Conjugates and Checkpoint Antibodies)

FEATURING Peter Johnson
  • 77 views
  • August 19, 2019
11:53

Indy Hematology Review

Hodgkin Lymphoma - Revolutionized Treatment Options Using Brentuximab Vedotin and Checkpoint Inhibitors

FEATURING Bruce Cheson
  • 394 views
  • June 7, 2019
  • 2
24:36

Stephen M. Ansell

Hodgkin Lymphoma - Immunotherapy

  • 197 views
  • November 12, 2018
  • 1
20:54

2018 Pan Pacific Lymphoma Conference

Beyond Checkpoint Inhibitors for Hodgkin Lymphoma

FEATURING Stephen M. Ansell
  • 42 views
  • August 23, 2018
10:00

2018 Pan Pacific Lymphoma Conference

The Tumor Microenvironment Using Immune Checkpoint Inhibitors

FEATURING John Gribben
  • 491 views
  • August 23, 2018
  • 3
15:08

2018 Pan Pacific Lymphoma Conference

Immune Evasion and Engagement in Lymphoma: The Mechanisms of Impairment of an Adequate Antitumor Immune Response in Lymphoma

FEATURING Stephen M. Ansell
  • 166 views
  • August 15, 2018
08:17

2018 Pan Pacific Lymphoma Conference

How Can We Activate the Anti-tumor Immune Response in Lymphoma?

FEATURING Stephen M. Ansell
  • 233 views
  • August 15, 2018
05:17

Loretta Nastoupil

Combination Immunotherapy for Checkpoint Inhibitors in Lymphoma Immunotherapy

  • 353 views
  • June 28, 2018
  • 1

Immune Checkpoint Inhibitors in Hodgkin Lymphoma

No subtopics